Clinical Trials Details

LUNGMAP Master Protocol (Lung)

A MASTER PROTOCOL to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

Objective

Key eligibility: Lung-MAP screening protocol; previously treated; Stage IV or recurrent NSCLC; all histologic types.

» Learn more about this trial

Clinical Trial Categories

• Cancers and Other Neoplasms